Navigation Links
Myoscience Announces the Completion of Enrollment in the Campbell Clinic Study
Date:10/31/2018

Myoscience, Inc. announced today that it has completed enrollment in its randomized, controlled trial at the Campbell Clinic in Memphis, Tennessee. This study enrolled 125 patients and compares the effect of cryoanalgesia using the iovera° system to the standard of care for managing pain after total knee replacement surgery (TKA).

The Myoscience iovera° system is currently being used to treat chronic and perioperative knee pain. The Campbell Clinic study will demonstrate how cryoanalgesia can significantly reduce opioid consumption after TKA, and lead to improved physical function and enhanced recovery. Analysis of interim data confirms that cryoanalgesia with the iovera° system can be a preferred treatment for relieving postoperative TKA pain.

“I am very impressed with the results of this prospective randomized study thus far. The positive effect of the iovera° system has exceeded our original expectations”, stated Dr. William Mihalko, MD, Principal Investigator for this study. “Having a technology as effective as this to combat excessive opioid use after primary TKA can be a game changer for many patients. Many of us will adopt the use of the technology on a regular basis at my institution,” he added.

The company will be sharing these interim results during a sponsored symposium at the upcoming American Association of Hip and Knee Surgeons (AAHKS) annual meeting in Dallas, Texas. The symposium “Cryoanalgesia: A Path to an Opioid-Free TKA, Pre-op through Rehab,” will be held from 10 a.m. to noon on November 1.

Timothy I. Still, President and CEO of Myoscience stated, “I share Dr. Mihalko’s enthusiasm about iovera°. We look forward to sharing these interim results during the AAHKS meeting in a few days.”

For additional information, please visit http://www.iovera.com or email us directly at mediarelations(at)myoscience(dot)com.

ABOUT MYOSCIENCE
Silicon Valley, California-based Myoscience is a privately-held medical device company committed to making its platform technology, the iovera° system, the standard of care for the treatment of peripheral nerves. The iovera° treatment is powered by a patented device that enables cryoneurolysis. The ioveraº system is 510k cleared in the U.S. for the blocking of pain, the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days and general surgical use. For more information, please visit http://www.iovera.com.

© 2018 Myoscience. All rights reserved. iovera° is a trademark of Myoscience. MKT-0524 REV A

Read the full story at https://www.prweb.com/releases/myoscience_announces_the_completion_of_enrollment_in_the_campbell_clinic_study/prweb15878597.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Molecular Devices Announces Brand Identity for Its Newly-Formed Biologics Business Unit
2. AMIA Announces 2018 Signature Award and Leadership Award Recipients
3. Voxx Analytics Announces Release of Voxx.Gateway for Medical Device and Early-Stage Life Science Companies
4. GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
5. LabRoots Announces Winner for the Second Annual Summer Textbook Scholarship
6. NanoScientific Symposium on SPM at SUNY Polytechnic Announces Registration for Live Stream of Event Sept. 19, 2018
7. Nanovis Announces Successful Completion of $5.5 Million Investment Round To Fund Technology-Driven Growth
8. The Freedom from Cancer Startup Challenge Announces Companies Advancing 100+ Cancer Inventions
9. SkylineDx Announces Prognostic Tool to be Used as Part of Major New Myeloma Clinical Trial
10. NanoValent Pharmaceuticals Announces Exclusive Global Licensing Agreement with Children’s Hospital Los Angeles and Completion of First Wave of Financing
11. Pittcon Announces 2018 Award Recipients for Outstanding Achievements in Analytical Chemistry and Applied Spectroscopy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance Seminars today ... 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is always selected ... training will kick off with a compendial treatment of Data Integrity fundamentals. After ...
(Date:5/15/2019)... ... 15, 2019 , ... Milton Hershey School® has named William Charles Ballough Harding ... biomedical industry, where he is changing lives by creating solutions to global healthcare challenges ... the vision of our founders – Milton and Catherine Hershey – who always hoped ...
(Date:5/7/2019)... (PRWEB) , ... May 06, 2019 , ... ... go-to resource for the growing number of repositories being asked to store cellular ... grateful to the team of contributors who are world leaders, who have shared ...
(Date:5/2/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars: , CLINICAL TRIALS , May 7 – Oncology Clinical Trials – The ...
Breaking Biology Technology:
(Date:5/22/2019)... TOWNSHIP, N.J. (PRWEB) , ... May 22, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Industrial Production Processes (IPP) Ltd has ...
(Date:5/21/2019)... ... May 21, 2019 , ... Experiential tourism, a trend ... demand over the last several years. And according to a recent report by ... soon. In fact, more and more travelers are wanting their journeys to be ...
(Date:5/21/2019)... ... 21, 2019 , ... Zer0 to 5ive, an award-winning strategic ... celebrate launched a new startup package, 0to5 Launch, to provide seed-stage and early-stage ... to attract talent and investors. , “We launched our Zer0 to 5ive Roadmap™ ...
Breaking Biology News(10 mins):